Nanobiotix is trading 6.38% up at $40.20 in pre-market, with no clear company-specific catalyst identified for August 7, 2026.
- Its investor-relations page lists a July 30 voting-rights and share-capital update as the latest identifiable disclosure, not a fresh earnings release or major announcement.
- Broader futures are mixed, while the S&P 500 and Nasdaq are modestly higher, so market sentiment does not clearly explain the move.